BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SICC - ECPv5.7.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://sicc.ch
X-WR-CALDESC:Events for SICC
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20220215T103000
DTEND;TZID=Europe/Zurich:20220215T113000
DTSTAMP:20260429T165704
CREATED:20220128T085652Z
LAST-MODIFIED:20220210T132321Z
UID:6439-1644921000-1644924600@sicc.ch
SUMMARY:How can Swiss biotech and medtech start-ups and SMEs harness their innovative businesses and take them to the Indian market?
DESCRIPTION:Agenda: \n10:30 am CET: Welcome & Introduction  by Philippe Reich\, Chairman SICC/President  SICC Switzerland \n10:35 am CET: Investment Opportunities in India by Richard Fritschi\, Vice President SICC Switzerland \n10:40 am CET: Panel Discussion Moderator: Dr. Goutam Bhattacharya\, Partner and Chair\, Patents Practice\, K&S Partners \nPanelists: \nDr. Michael Altorfer\, CEO\, Swiss Biotech Association \nSudeshna Banerjee\, Partner\, K&S Partners \nDirk Reuter (SIGVARIS AG) and Olaf Nitz (CODAN ARGUS AG)\, Swiss Medtech \nAparna Kumaraswamy\, Lead\, Healthtech\, Innovation and Startup Partnerships\, Swissnex \n11:15 am CET: Q&A \n11:25 am CET: Closing by Abubaker Koya\, Vice Chairman SICC / President SICC India
URL:https://sicc.ch/event/how-can-swiss-biotech-and-medtech-start-ups-and-smes-harness-their-innovative-businesses-and-take-them-to-the-indian-market/
LOCATION:Webinar\, India
ATTACH;FMTTYPE=image/jpeg:https://sicc.ch/wp-content/uploads/2022/01/3-How-can-Swiss-biotech-and-medtech-start.jpg
END:VEVENT
END:VCALENDAR